Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 2017;91(3):566–74.

Article  PubMed  CAS  Google Scholar 

Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, et al. Membranous nephropathy. Nat Rev Dis Primers. 2021;7(1):69.

Article  PubMed  Google Scholar 

Sethi S. New “antigens” in membranous nephropathy. J Am Soc Nephrol. 2021;32(2):268–78.

Article  PubMed  CAS  Google Scholar 

Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371(24):2277–87.

Article  PubMed  PubMed Central  Google Scholar 

Ronco P, Plaisier E, Debiec H. Advances in membranous nephropathy. J Clin Med. 2021;10(4):607.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, et al. Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol. 2019;30(6):1123–36.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, et al. In patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol. 2021;32(3):695–706.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wada Y, Iyoda M, Suzuki T, Tachibana S, Kanazawa N, Matsumoto K, et al. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis. Virchows Arch. 2021;479(5):997–1005.

Article  PubMed  CAS  Google Scholar 

Miyake K, Adachi K, Watanabe M, Sasatomi Y, Ogahara S, Abe Y, et al. Parasites alter the pathological phenotype of lupus nephritis. Autoimmunity. 2014;47(8):538–47.

Article  PubMed  PubMed Central  Google Scholar 

Ward F, Bargman JM. Membranous lupus nephritis: the same, but different. Am J Kidney Dis. 2016;68(6):954–66.

Article  PubMed  Google Scholar 

Iwakura T, Ema C, Isobe S, Fujikura T, Ohashi N, Kato A, et al. Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. Sci Rep. 2022;12(1):2967.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang C, Liu Y, Zhang M, Yang F, Xu F, Shi S, et al. Glomerular exostosin as a subtype and activity marker of class 5 lupus nephritis. Clin J Am Soc Nephrol. 2022;17(7):986–93.

Article  PubMed  PubMed Central  CAS  Google Scholar 

De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC. A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol. 2017;28(2):421–30.

Article  PubMed  Google Scholar 

Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, et al. Anti-phospholipase A2 receptor (PLA2R) antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy. PLoS ONE. 2016;11(6):e0158154.

Article  PubMed  PubMed Central  Google Scholar 

Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709–15.

Article  PubMed  CAS  Google Scholar 

Gunnarsson I, Schlumberger W, Rönnelid J. Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis. 2012;59(4):585–6.

Article  PubMed  Google Scholar 

Garcia-Vives E, Solé C, Moliné T, Alvarez-Rios AM, Vidal M, Agraz I, et al. Antibodies to M-type phospholipase A2 receptor (PLA(2)R) in membranous lupus nephritis. Lupus. 2019;28(3):396–405.

Article  PubMed  CAS  Google Scholar 

Iwakura T, Ema C, Sato T, Isobe S, Fujikura T, Ohashi N, et al. Primary membranous nephropathy with enhanced staining of exostosin 1/exostosin 2 in the glomeruli: a report of 2 cases. Kidney Med. 2021;3(4):669–73.

Article  PubMed  PubMed Central  Google Scholar 

Monga G, Mazzucco G, Basolo B, Quaranta S, Motta M, Segoloni G, et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol. 1993;6(3):249–58.

PubMed  CAS  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

Article  PubMed  CAS  Google Scholar 

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.

Article  PubMed  PubMed Central  Google Scholar 

Yamazaki T, Takahashi H, Takeuchi K, Sakamoto E, Tominaga K, Sakurabayashi S, et al. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report. BMC Nephrol. 2023;24(1):218.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shearn MA, Hopper J Jr, Biava CG. Membranous lupus nephropathy initially seen as idiopathic membranous nephropathy Possible diagnostic value of tubular reticular structures. Arch Intern Med. 1980;140(11):1521–3.

Article  PubMed  CAS  Google Scholar 

Wen YK, Chen ML. Clinicopathological study of originally non-lupus “full-house” nephropathy. Ren Fail. 2010;32(9):1025–30.

Article  PubMed  Google Scholar 

Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G. Delayed onset of systemic lupus erythematosus in patients with “full-house” nephropathy. Pediatr Nephrol. 1999;13(8):683–7.

Article  PubMed  CAS  Google Scholar 

Yamada T, Itagaki F, Aratani S, Kawasaki S, Terada K, Mugishima K, et al. A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset. CEN Case Rep. 2019;8(4):301–7.

Article  PubMed  PubMed Central  Google Scholar 

Sam R, Joshi A, James S, Jen KY, Amani F, Hart P, et al. Lupus-like membranous nephropathy: Is it lupus or not? Clin Exp Nephrol. 2015;19(3):395–402.

Article  PubMed  CAS  Google Scholar 

Simenhoff ML, Merrill JP. The spectrum of lupus nephritis. Nephron. 1964;1:348–75.

Article  PubMed  CAS  Google Scholar 

Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, et al. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med. 1983;52(208):471–87.

PubMed  CAS  Google Scholar 

Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int. 1983;24(3):377–85.

Article